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Cerebral malaria (CM), caused by Plasmodium falciparum infection, is a prevalent neuro-
logical disorder in the tropics. Most of the patients are children, typically with intractable
seizures and high mortality. Current treatment is unsatisfactory. Understanding the
pathogenesis of CM is required in order to identify therapeutic targets. Here, we argue
that cerebral energy metabolic defects are probable etiological factors in CM pathogenesis,
because malaria parasites consume large amounts of glucose metabolized mostly to
lactate. Monocarboxylate transporters (MCTs) mediate facilitated transfer, which serves to
equalize lactate concentrations across cell membranes in the direction of the concentration
gradient.The equalizing action ofMCTs is the basis for lactate’s role as a volume transmitter
of metabolic signals in the brain. Lactate binds to the lactate receptor GPR81, recently
discovered on brain cells and cerebral blood vessels, causing inhibition of adenylyl cyclase.
High levels of lactate delivered by the parasite at the vascular endothelium may damage
the blood–brain barrier, disrupt lactate homeostasis in the brain, and imply MCTs and the
lactate receptor as novel therapeutic targets in CM.
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CEREBRAL MALARIA
Malaria is caused by the protozoan parasite Plasmodium. About
two million children die each year world-wide (Breman, 2001),
mainly due to severe complications, especially from cerebral
malaria (CM), of Plasmodium falciparum infection, the major-
ity in sub-Saharan Africa, but also in Southeast Asia and South
America. In developed countries, CM affects mainly returning
travelers. Brain edema, lactate accumulation, and intracra-
nial hypertension are important characteristics of CM, and
untreated CM often leads to coma and death within 24 h (New-
ton and Krishna, 1998). CM survivors sometimes suffer from
general disorders such as acidosis, as well as more speciﬁc
neurological disorders such as ataxia, epilepsy, and blindness.
However, the pathogenesis of CM remains unclear. Despite
intense research, no effective vaccine is yet available, and the
problem of drug-resistant malaria is increasing (Mariga et al.,
2004).
CM FROM CIRCULATING ASEXUAL Plasmodium falciparum
The Plasmodium parasite invades erythrocytes as part of its asex-
ual life cycle within the human host. It matures within these blood
cells (Plasmodium-invaded red blood cells, PRBC) to the tropho-
zoite and schizont stages. It then disappears from the peripheral
circulation and is sequestrated in the vascular beds of critical
organs such as the brain (Kristensson et al., 2013). Progression
to CM is closely linked to erythrocytes containing mature stages
of P. falciparum conﬁned in the brainmicrovasculature (Dorovini-
Zis et al., 2011) and host immunocompentent cells targeting
the malaria parasite (Idro et al., 2005). Mechanisms by wish an
intraerythrocytic parasite lodged in the vascular space of the brain
can elicit such dramatic neurological effects necessarily involve
local and systemic metabolic intermediates, as well as the trans-
port systems for water and metabolites that link the membranes
of the PRBC to the blood–brain barrier (BBB) and the end-feet of
astrocytes.
DYNAMICS OF BLOOD AND BRAIN LACTATE IN CM
Several factors contribute to the accumulation of lactate in
brain tissue in CM. The lack of a functional citric acid (TCA)
cycle in human and murine Plasmodium parasites makes them
largely reliant on glycolysis to fulﬁll their very substantial
energy requirements (Sherman, 1998). Erythrocytes infected
with mature parasites at the trophozoite stage consume glu-
cose two orders of magnitude faster than normal, uninfected
erythrocytes (Scheibel et al., 1979; Roth et al., 1982) with com-
mensurate generation of lactic acid (Pfaller et al., 1982) i.e., at
5–100 times the rates of uninfected erythrocytes (Zolg et al.,
1984). The resulting quantities of lactate leave the cells as directed
by the concentration gradient. At rest, lactate in brain also is
transported from brain tissue to plasma, but given the high
rate of release of lactate from Plasmodium infected erythrocytes
sequestered on the endothelial cells, lactate generated by para-
sites moves from the plasma to brain tissue down a concentration
gradient.
CEREBRAL LACTATE CONTENT AND TRANSPORT
The quantities of lactate produced by the parasites compete with
the lactate generated in the host’s own brain metabolism for
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transport to or from the brain tissue. A system of transporters
of lactate is present at the parasite surface as H++-coupled mono-
carboxylate transporters (MCTs) with features in common with
members of the MCT family of higher eukaryotes (Kanaani
and Ginsburg, 1991, 1992; Elliot et al., 2001). The MCT fam-
ily members are well characterized in human brain (Bergersen
et al., 1999, 2001; Pierre and Pellerin, 2005; Bergersen, 2007;
Lauritzen et al., 2013a,b). In general, MCT1 is at the vascu-
lar endothelium, MCT4 in astrocytes, and MCT2 on neurons.
Microglia expresses MCT1 and MCT2 after cerebral ischemia
(Moreira et al., 2009). Both the MCTs and the lactate recep-
tor GPR81 display afﬁnities for L-lactate in the low mM range
(Cai et al., 2008) that are consistent with the range of extra-
cellular lactate concentrations measured by microdialysis in the
brain tissue in vivo in human subjects (Abi-Saab et al., 2002;
Jalloh et al., 2013).
LACTATE FLUX RECEPTOR ACTION AT THE BLOOD–BRAIN
BARRIER
The BBB is constituted by the tight junctions of the endothe-
lium of cerebral microvessels and capillaries. Interaction between
lactate and lactate transport systems is likely to be perturbed at
the BBB that is an important site of CM pathogenesis accord-
ing to data from human autopsies, animal models, and in vitro
cell cultures (Tripathi et al., 2007). At the BBB interfaces between
the brain parenchyma and the parasite infected erythrocytes, any
impairment of the integrity of endothelial cells of the cerebral
microvasculature will lead to cerebral edema and lactic acido-
sis by the disruption of ion and solute homeostasis that follows
increased membrane permeability. Normally, lactate enters the
brain by ﬁrst being transported through the endothelial cells
and then diffusing extracellularly in the brain interstitial space
and intracellularly after transport by the MCTs. Lactate down-
regulates cAMP by interacting with GRP81, which is exposed on
the luminal as well as the abluminal membranes of the endothe-
lial cells and to a lesser extent on the membranes of astrocytes
(Lauritzen et al., 2013a,b).
CM ASSOCIATION WITH ELEVATED LACTATE
Association of CM with increased CSF (cerebral spine ﬂuid) lac-
tate is now well established. As a signaling molecule as well as
a substrate for energy metabolism, brain lactate is an impor-
tant diagnostic marker in clinical settings. Lactate concentrations
can be used to monitor disease progress and during trials of
drug effects in CM. Results from clinical settings and animal
models provide convincing evidence of increased lactate con-
centrations both in extracellular ﬂuid and CSF in CM. Several
investigators conﬁrmed lactate as the single best indicator of
prognosis (White et al., 1985; Krishna et al., 1994) when mea-
sured in CSF of patients infected with P. falciparum (Tosti et al.,
2007). In the patients, CSF concentrations correlated with the
state of the disease (White et al., 1985), with death observed at
levels higher than 6–9 mM lactate. Survivors always had less than
3.4 mM.
More than 80% of children from Malawi, Kenya, and Gam-
bia with CM (Waller et al., 1991) with elevated CSF pressure
revealed 40% higher lactate concentrations compared to normal
(Newton et al., 1994; Potchen et al., 2012). The combination
of elevated pressure and elevated lactate often is fatal (Newton
et al., 1994, 1997), with most autopsies revealing high brain lac-
tate concentrations (SenGupta and Naraqi, 1992; Walker et al.,
1992). In adult Thai patients, CNS lactate in CSF at twice the
normal value was associated with 100% mortality, suggestive
of metabolic disturbances in the brain, indicative of a funda-
mental pathological process (Dorovini-Zis et al., 2011). Declining
lactate during CM is associated with recovery, conﬁrming that
severe lactacidosis is a reliable indicator of brain damage, (New-
ton, 2005). Similar lactate proﬁles are observed in murine CM
models, when brain lactate increases a few days post-infection
(Sanni et al., 2001).
ASSOCIATION WITH MALARIA RETINOPATHY AND LACTATE
Malaria retinopathy occurs in approximately two-thirds of pedi-
atric patients with CM (Beare et al., 2004, 2006). It is characterized
by retinal whitening, vessel changes and retinal hemorrhages.
Correlation between malaria retinopathy and the severity of
clinical CM symptoms has consistently been shown, and exam-
ination of the retina by ophthalmoscopy is useful for diagnosing
CM (Beare et al., 2011). Increased plasma lactate levels are
associated with the severity of retinopathy and CM, suggest-
ing that the microvascular obstruction observed in the retina
reﬂects systemic and cerebral microvascular obstruction and focal
ischemia (Maude et al., 2009a). The eye is an easily examined,
and the retina is developmentally a part of the brain and its
vasculature a continuation of the cerebral vasculature. Con-
sequently there is increasing attention on retinal pathology in
malaria, with the perspective of diagnosis as well as of under-
standing mechanisms in CM (Maude et al., 2009b; White et al.,
2009; Beare et al., 2011). Yet, the cascade of reactions involv-
ing lactate and its relation to malaria retinopathy is not fully
understood.
MOUSE MODELS OF CM
The present perspective focuses on the critical role of lactate in the
etiology and development of CM, although CM likely has a mul-
tifactorial pathogenesis. Murine models are critical to the study of
mechanisms of underlying symptoms observed in CM (Hunt and
Grau, 2003; Rénia et al., 2010; Riley et al., 2010). In humans, the
signs typically encountered with CM include lactacidosis, seizures,
brain edema (Polder et al., 1992; Potchen et al., 2012), and coma,
followed by death (Rest, 1982; Hunt and Grau, 2003; Medana
and Turner, 2006). Lactate accumulation is associated with
decreased brain perfusion and brain hypoxia in a mouse model
(Promeneur et al., 2013). These observations indicate intravas-
cular obstruction and reduced perfusion of brain microvessels
in CM.
To resolve the mechanisms of these changes, it is necessary
to determine the cellular expression, localization and potential
redistribution of the brain MCTs (MCT1, MCT2, MCT4), as
well as the lactate receptor (GPR81), to reveal the dynamics of
lactate’s role in CM. This is possible with the mouse models
of CM, established by infection with the rodent malaria par-
asite P. berghei ANKA in susceptible strains, C57BL/6 (Rest,
1982) or CBA/J (Penet et al., 2005). In vivo studies of the latter
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model demonstrated massive brain edema coupled to lactacido-
sis associated with compression of cerebral arteries, ultimately
causing coma and death, but no attempt was made to study
the brain lactate transport systems (Penet et al., 2005). Using
the CM C57BL/6 mouse model, Promeneur and collaborators
(Promeneur et al., 2013) found that the water channel aqua-
porine 4 (AQP4) was downregulated in CM. Also, knock-out
C57BL/6 mice lacking AQP4 succumbed earlier to P. berghei
ANKA infection and were more severely affected than wild type
mice, indicating that the water channel is protective in CM. It
is particularly important to repeat these experiments in GPR81
knock-out mice to determine whether volume transmission fol-
lowed by remote action at the lactate receptor is an important
factor in CM.
MCT AND GPR81 IN CM
In the brain and retina, MCTs, like AQP4, are highly expressed
in ependymal cells and astrocytes with polarized distribution in
end-feet membranes facing cerebral capillaries and pia mater
(Bergersen, 2007). GPR81 has a similar distribution (Lauritzen
et al., 2013a,b). MCTs have also been identiﬁed in retinal sections
(Bergersen et al., 1999) and unpublished results reveal GPR81
staining in human retinal sections (Kolko and Bergersen, in prepa-
ration). In addition MCT1 and GPR81 are highly expressed in
the endothelial cells. The strategic locations at the blood–brain
and cerebrospinal ﬂuid–brain interfaces indicate that MCTs and
GPR81 are major factors in the regulation of lactate movement
into and out of the brain. Such movements were suggested already
by early in vivo work (Gjedde et al., 1975) and are now ﬁrmly
established (van Hall et al., 2009). Lactate receptor actions have
been demonstrated in brain, reducing cAMP (apparent IC50
29 mM; Lauritzen et al., 2013a,b) and neuronal calcium spik-
ing (apparent IC50 4.2 mM; Bozzo et al., 2013) through GPR81
activation. In addition, lactate stimulates locus coeruleus neu-
rons (apparent IC50 0.7 mM; Tang et al., 2014), ascribed to a
receptor other than GPR81. These observations and the vol-
ume transmitter role of lactate (Bergersen and Gjedde, 2012),
whereby lactate diffuses through large volumes of brain tissue
to produce distant receptor effects, therefore imply actions of
lactate produced by malaria parasites as important factors in
CM.
Epileptic seizures occur in more than 70% of CM patients on
admission (Newton et al., 2000; Idro et al., 2010). Elevated lac-
tate concentrations in the brain are highly correlated with the
severity of repeated seizures commonly observed in CM. Simi-
larly, seizures in temporal lobe epilepsy (TLE) with hippocampal
sclerosis, known as mesial temporal lobe epilepsy (MTLE), are
correlated with high lactate levels as observed by microdialysis
in epileptic patients (During et al., 1994). Brain MCTs expres-
sions and distributions might be inﬂuenced by multiple forms
of brain pathology including MTLE, stroke, meningitis, neu-
romyelitis optica, and brain tumors (Bergersen, 2007; Lauritzen
et al., 2011, 2012, 2013a,b). Observations in MTLE and other
neuropathological disorders resemble in some respects, the CM-
related clinical and pathological status (i.e., seizures, lactacidosis).
However, the role of lactate and the receptor action and transport
in CM and other disease states need to be clariﬁed.
HYPOTHESIS OF A NEW FACTOR IN CM
Based on the extant evidence, we claim that the lactate transporters
and the lactate receptor GPR81 together are an essential factor in
the pathophysiology of CM. The most obvious scenario (Figure 1)
under this hypothesis is that lactate, profusely released from
Plasmodium infected erythrocytes sequestered at the capillary
endothelium, excessively down-regulates cAMP via GPR81. High
concentrations of lactate will reach receptors both at the luminal
and abluminal surface of the endothelial cells, because of the pres-
ence of MCT1 (Lauritzen et al., 2011) as well as GPR81 (Lauritzen
et al., 2013a,b) at both sides of the endothelium. Normally as well
as in disease, cAMP is perhaps the most potent signaling molecule
to stabilize the endothelial barrier, and also regulates inﬂamma-
tion response and vascular tone (Roberts and Dart, 2014; Schlegel
and Waschke, 2014). It acts on three classes of proteins: protein
kinase A (PKA), cyclic-nucleotide-gated ion channels, and Epacs
FIGURE 1 | Proposed action of extreme quantities of Plasmodium
derived lactic acid on brain vascular endothelium. (A) Lactate
penetrating the endothelial cells through MCT1 activates the lactate
receptor GPR81, which is situated on both sides of the endothelium, to
cause down-regulation of cAMP by inhibiting adenylyl cyclase activity.
(B) Reduced levels of cAMP can lead to vasoconstriction and endothelial
dysfunction with weakening of cell–cell junctions ultimately causing
break-down of the blood-brain-barrier. Not shown: the GPR81 mediated
effects may act in concert with pH effects of lactic acid and with other
deleterious agents from the protozoon. Lactate penetrating the
endothelium may also act on GPR81 expressed on neurons and to a lesser
degree on astrocytic perivascular end-feet.
www.frontiersin.org May 2014 | Volume 8 | Article 2 | 3
Mariga et al. Lactate actions in cerebral malaria
(exchange proteins directly activated by cAMP). The Epacs consti-
tute a family of guanine-nucleotide-exchange factors for the small
Ras-related GTPases Rap1 and Rap2. Both PKA and Rap1 can
cause Rac1-mediated strengthening of adherens junctions and of
the actin cytoskeleton (Schlegel and Waschke, 2014).
Extremedown-regulationof cAMPcan therefore be expected to
cause deterioration of the endothelium, including break-down of
regulated trans-endothelial transport andof the junctions between
endothelial cells, i.e., break-down of the BBB (Figure 1). In
addition, increased vascular tone (Roberts and Dart, 2014) may
aggravate the hypoperfusion caused by clogging of microvessels
by sequestered erythrocytes. The effects via GPR81, and possibly
other lactate receptors (cf. Tang et al., 2014), may converge with
effects of acidiﬁcation caused by proton from the parasite pro-
duced lactic acid, as well as with other deleterious compounds
originating in the Plasmodium infected erythrocytes (Aird et al.,
2014).
Within the brain parenchyma, excessive lactate concentrations
delivered by the parasites must be expected to perturb the vol-
ume transmitter function of lactate (Bergersen and Gjedde, 2012),
although the concentration of lactate will decrease with the dis-
tance from the parasites, which are conﬁned to the vasculature.
The vascular end-feet processes of astrocytes have relatively low
GPR81 concentrations, while the synaptic membranes of excita-
tory synapses have the highest concentrations of GPR81 (Lauritzen
et al., 2013a,b), but are at a greater distance from the parasites. The
effects of excessive lactate in the parenchyma are harder to predict
than those on the BBB, but they are expected to be exacerbated
in CM, because lactate induced down-regulation of cAMP will
upregulate MCT1 at the endothelial plasma membrane (Smith
et al., 2012).
Inﬂammatory responses through the innate immune system
may serve to conﬁne the infection or cause serious tissue damage,
the relative weight of these effects depending on genetic char-
acteristics of the Plasmodium and of the host (Wu et al., 2014).
Careful dissection of the mechanisms may reveal ways to augment
antiparasite mechanisms but suppress tissue damage. A recent
paper (Hoque et al., 2014) found that lactate by activating GPR81
reduced tissue injury in disease models. The fact that this effect
was mediated down stream through arrestin beta-2 rather than
cAMP predicts the possibility of separately modifying deleterious
and beneﬁcial effects of GPR81 activation.
Our hypothesis may be tested in mouse models of CM. The
role of GPR81 can be ascertained by inducing CM in GPR81
knock-out mice. This will reveal whether the lack of the lactate
receptor confers resistance to CM and/or ameliorates the pathol-
ogy and outcome, in which case GPR81 antagonists would offer
novel treatment for CM. GPR81 antagonists are not available at
present, but may soon be. Further, MCT1 blockers, which are
presently introduced in cancer therapy (Parks et al., 2013; Draoui
et al., 2014) may slow the release of lactate from the infected
erythrocytes and its transfer across the endothelium. If so, they
would offer another novel therapy against CM. The existence of
MCT blockers that selectively inhibit lactate inﬂux but not efﬂux
(Draoui et al., 2014) would allow the action to be restricted to
the luminal side of the endothelium, avoiding possibly deleteri-
ous actions of the drugs on the brain parenchyma, which may
also be avoided by using GPR81 and MCT antagonists that are
hydrophilic and do not penetrate the BBB. The hypothesis can
be further tested by analysis of MCT and GPR81 mRNAs and
protein expressions and by immunohistochemistry by light and
electron microscopy of the brain in CM mice and non-CM con-
trols. It is particularly important to examine the hippocampal
formation, in view of its central role in epileptogenesis and in
view of the demonstrated roles of MCTs in human epilepsy and
animal models of TLE (Lauritzen et al., 2013a,b). In addition, reti-
nal sections must be examined to identify the expression pattern
of MCTs and GPR81 in CM mice. The possible impact of anti-
malarial drugs on lactate transport and receptor activity should be
tested.
CONCLUSION
Studies on lactate transport and receptor action in CM are
expected to provide important new insights into the pathogenesis
of CM, and to identify novel therapeutic targets.
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